谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Preliminary Safety, Efficacy, And Pharmacokinetics (Pk) Results Of Kn046 (Bispecific Anti-Pd-L1/Ctla4) From A First-In-Human Study In Subjects With Advanced Solid Tumors.

Jermaine Coward,Vinod Ganju, Ramin Behzadigohar, Kenneth Kwong,June Xu,Hardy Van,Paul Kong,Fei Yang, Lisa Chen,Kangping Guo, Mei Liu,Danming Zhu, Lara Kristina Donato,Ting Xu,Gary Edward Richardson

JOURNAL OF CLINICAL ONCOLOGY（2019）

引用 9|浏览31
暂无评分
关键词
pharmacokinetics,advanced solid tumors,anti-pd-l1/ctla4,first-in-human
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要